Cognitive impairment and its relation with disease measures in mildly disabled patients with relapsing–remitting multiple sclerosis: baseline results from the Cognitive Impairment in Multiple Sclerosis (COGIMUS) study

Abstract

Background

Cognitive impairment is a common symptom of multiple sclerosis (MS), but the association between cognitive impairment and magnetic resonance imaging (MRI) disease measures in patients with relapsing–remitting (RR) MS is unclear.

Objectives

To study the prevalence of cognitive impairment and its relation with MRI disease measures in mildly disabled patients with RRMS.

Methods

Patients aged 18–50 years with RRMS (McDonald criteria) and an Expanded Disability Status Scale (EDSS) score ≤4.0, who were enrolled in the Cognitive Impairment in Multiple Sclerosis (COGIMUS) study, underwent baseline standardized MRI complete neurological examination and neuropsychological testing.

Results

A total of 550 patients were enrolled, 327 of whom underwent MRI assessments. Cognitive impairment (impaired performance in ≥3 cognitive tests) was present in approximately 20% of all patients and in the subgroup who underwent MRI. T2 hyperintense and T1 hypointense lesion volumes were significantly higher in patients with cognitive impairment (defined as impaired performance on at least three tests of the Rao’s battery) than those without. EDSS score was also significantly higher in cognitively impaired than in cognitively preserved patients. Disease duration, depression, and years in formal education did not differ significantly between cognitively impaired and cognitively preserved patients. T2 lesion volume, performance intelligence quotient, and age were significant predictors of cognitive impairment in this population. Weak correlations were found between performance on individual cognitive tests and specific MRI measures, with T1 and T2 lesion volumes correlating with performance on most cognitive tests.

Conclusions

Cognitive impairment occurs in approximately one-fifth of mildly disabled patients with MS and is associated with specific MRI disease measures. Assessment of cognitive function at diagnosis could facilitate the identification of patients who may benefit from therapeutic intervention with disease-modifying therapies to prevent further lesion development.

Keywords

cognitive impairment cognitive function multiple sclerosis neuropsychological assessment

Get full access to this article

View all access options for this article.

References

1 Amato MP Zipoli V Portaccio E . Multiple sclerosis-related cognitive changes: a review of cross-sectional and longitudinal studies. J Neurol Sci 2006; 245: 41–46.

2 Ghaffar O Feinstein A . The neuropsychiatry of multiple sclerosis: a review of recent developments. Curr Opin Psychiatry 2007; 20: 278–285.

3 Rao SM Leo GJ Bernardin L Unverzagt F . Cognitive dysfunction in multiple sclerosis. I. Frequency, patterns, and prediction. Neurology 1991; 41: 685–691.

4 Rovaris M Filippi M . MRI correlates of cognitive dysfunction in multiple sclerosis patients. J Neurovirol 2000; 6(Suppl. 2): S172–S175.

5 Benedict RH Bobholz JH . Multiple sclerosis. Semin Neurol 2007; 27: 78–85.

6 Deloire MS Salort E Bonnet M . Cognitive impairment as marker of diffuse brain abnormalities in early relapsing remitting multiple sclerosis. J Neurol Neurosurg Psychiatry 2005; 76: 519–526.

7 Haase CG Tinnefeld M Lienemann M Ganz RE Faustmann PM . Depression and cognitive impairment in disability-free early multiple sclerosis. Behav Neurol 2003; 14: 39–45.

8 Glanz B Holland C Gauthier S . Cognitive dysfunction in patients with clinically isolated syndromes or newly diagnosed multiple sclerosis. Mult Scler 2007; 13: 1004–1010.

9 Amato MP Ponziani G Siracusa G Sorbi S . Cognitive dysfunction in early-onset multiple sclerosis: a reappraisal after 10 years. Arch Neurol 2001; 58: 1602–1606.

10.

10 Kujala P Portin R Ruutiainen J . The progress of cognitive decline in multiple sclerosis. A controlled 3-year follow-up. Brain 1997; 120: 289–297.

11.

11 Sartori E Edan G . Assessment of cognitive dysfunction in multiple sclerosis. J Neurol Sci 2006; 245: 169–175.

12.

12 Benedict RH Fischer JS Archibald CJ . Minimal neuropsychological assessment of MS patients: a consensus approach. Clin Neuropsychol 2002; 16: 381–397.

13.

13 Rao S . Cognitive Function Study Group, N. A manual for the brief repeatable battery of neuropsychological tests in multiple sclerosis. New York: National Multiple Sclerosis Society; 1990.

14.

14 Achiron A Polliack M Rao SM . Cognitive patterns and progression in multiple sclerosis: construction and validation of percentile curves. J Neurol Neurosurg Psychiatry 2005; 76: 744–749.

15.

15 Benedict RH Bruce JM Dwyer MG . Neocortical atrophy, third ventricular width, and cognitive dysfunction in multiple sclerosis. Arch Neurol 2006; 63: 1301–1306.

16.

16 Huijbregts SC Kalkers NF de Sonneville LM de Groot V Polman CH . Cognitive impairment and decline in different MS subtypes. J Neurol Sci 2006; 245: 187–194.

17.

17 Patti F Failla G Ciancio MR L’Episcopo MR Reggio A . Neuropsychological, neuroradiological and clinical findings in multiple sclerosis. A 3 year follow-up study. Eur J Neurol 1998; 5: 283–286.

18.

18 Lazeron RH de Sonneville LM Scheltens P Polman CH Barkhof F . Cognitive slowing in multiple sclerosis is strongly associated with brain volume reduction. Mult Scler 2006; 12: 760–768.

19.

19 Morgen K Sammer G Courtney SM . Evidence for a direct association between cortical atrophy and cognitive impairment in relapsing-remitting MS. Neuroimage 2006; 30: 891–898.

20.

20 American Psychiatric Association . Diagnostic and statistical manual of mental disorders DSM-IV-TR, fourth ed. Washington, DC: American Psychiatric Publishing Inc; 1994.

21.

21 Barbarotto R Laiacona M Frosio R Vecchio M Farinato A Capitani E . A normative study on visual reaction times and two stroop colour-word tests. Ital J Neurol Sci 1998; 19: 161–170.

22.

22 Hamilton M . Development of a rating scale for primary depressive illness. Br J Soc Clin Psychol 1967; 6: 278–296.

23.

23 Granger CV . Assessment of functional status: a model for multiple sclerosis. Acta Neurol Scand 1981; 64(Suppl. 87): 40–47.

24.

24 Fisk JD Ritvo PG Ross L Haase DA Marrie TJ Schlech WF . Measuring the functional impact of fatigue: initial validation of the fatigue impact scale. Clin Infect Dis 1994; 18(Suppl. 1): S79–S83.

25.

25 Kaufman AS Wang JJ . Gender, race, and education differences on the k-bit at ages 4 to 90 years. J Psychoeducational Assess 1992; 10: 219–229.

26.

26 Colombo L Sartori G Brivio C . La stima del quoziente intellettivo tramite l'applicazione del TIB (Test di Intelligenza Breve). G Ital Psicol 2002; 3: 613–637.

27.

27 Amato MP Portaccio E Goretti B . The Rao's Brief Repeatable Battery and Stroop Test: normative values with age, education and gender corrections in an Italian population. Mult Scler 2006; 12: 787–793.

28.

28 Camp SJ Stevenson VL Thompson AJ . Cognitive function in primary progressive and transitional progressive multiple sclerosis: a controlled study with MRI correlates. Brain 1999; 122: 1341–1348.

29.

29 Benedict RH Bruce J Dwyer MG . Diffusion-weighted imaging predicts cognitive impairment in multiple sclerosis. Mult Scler 2007; 13: 722–730.

30.

30 Sepulcre J Vanotti S Hernandez R . Cognitive impairment in patients with multiple sclerosis using the brief repeatable battery-neuropsychology test. Mult Scler 2006; 12: 187–195.

31.

31 Summers M Swanton J Fernando K . Cognitive impairment in multiple sclerosis can be predicted by imaging early in the disease. J Neurol Neurosurg Psychiatry 2008; 79: 955–958.

32.

32 Rudick RA Lee JC Simon J Fisher E . Significance of T2 lesions in multiple sclerosis: a 13-year longitudinal study. Ann Neurol 2006; 60: 236–242.

33.

33 Lynch SG Parmenter BA Denney DR . The association between cognitive impairment and physical disability in multiple sclerosis. Mult Scler 2005; 11: 469–476.

34.

34 Summers M Fisniku L Anderson V Miller D Cipolotti L Ron M . Cognitive impairment in relapsing–remitting multiple sclerosis can be predicted by imaging performed several years earlier. Mult Scler 2007; 13: 1–8.

35.

35 Lester K Stepleman L Hughes M . The association of illness severity, self-reported cognitive impairment, and perceived illness management with depression and anxiety in a multiple sclerosis clinic population. J Behav Med 2007; 30: 177–186.

36.

36 Turpin KV Carroll LJ Cassidy JD Hader WJ . Deterioration in the health-related quality of life of persons with multiple sclerosis: the possible warning signs. Mult Scler 2007; 13: 1038–1045.

37.

37 Rao SM Leo GJ Ellington L Nauertz T Bernardin L Unverzagt F . Cognitive dysfunction in multiple sclerosis. II. Impact on employment and social functioning. Neurology 1991; 41: 692–696.

38.

38 Amato MP Ponziani G Pracucci G Bracco L Siracusa G Amaducci L . Cognitive impairment in early-onset multiple sclerosis. Pattern, predictors, and impact on everyday life in a 4-year follow-up. Arch Neurol 1995; 52: 168–172.

39.

39 Benedict RH Cookfair D Gavett R . Validity of the minimal assessment of cognitive function in multiple sclerosis (MACFIMS). J Int Neuropsychol Soc 2006; 12: 549–558.